Tacrolimus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis
Condition:   Graft-versus-host Disease Interventions:   Drug: Cyclophosphamide;   Drug: Tacrolimus;   Drug: Mycophenolate Mofetil;   Drug: Ruxolitinib Sponsor:   Medical College of Wisconsin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2022 Category: Research Source Type: clinical trials

Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
Condition:   Graft Vs Host Disease Interventions:   Drug: Cyclophosphamide;   Drug: Abatacept;   Drug: Tacrolimus Sponsor:   NYU Langone Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2022 Category: Research Source Type: clinical trials

De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis
Condition:   Graft-versus-host Disease Interventions:   Drug: Cyclophosphamide;   Drug: Tacrolimus;   Drug: Mycophenolate Mofetil;   Drug: Ruxolitinib Sponsor:   Medical College of Wisconsin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2022 Category: Research Source Type: clinical trials

Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
Condition:   Graft Vs Host Disease Interventions:   Drug: Cyclophosphamide;   Drug: Abatacept;   Drug: Tacrolimus Sponsor:   NYU Langone Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2022 Category: Research Source Type: clinical trials

De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis
Condition:   Graft-versus-host Disease Interventions:   Drug: Cyclophosphamide;   Drug: Tacrolimus;   Drug: Mycophenolate Mofetil;   Drug: Ruxolitinib Sponsor:   Medical College of Wisconsin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2022 Category: Research Source Type: clinical trials

Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
Condition:   Graft Vs Host Disease Interventions:   Drug: Cyclophosphamide;   Drug: Abatacept;   Drug: Tacrolimus Sponsor:   NYU Langone Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2022 Category: Research Source Type: clinical trials

De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis
Condition:   Graft-versus-host Disease Interventions:   Drug: Cyclophosphamide;   Drug: Tacrolimus;   Drug: Mycophenolate Mofetil;   Drug: Ruxolitinib Sponsor:   Medical College of Wisconsin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2022 Category: Research Source Type: clinical trials